Ferring Pharma invests $250M in new Hyderabad facility

Switzerland-based Ferring Pharmaceuticals has recently laid the foundation for its R&D laboratory and manufacturing facility at Genome Valley, Hyderabad. The new facility will also add to the group’s global R&D capabilities and will cater to building a pool of novel research for emerging healthcare challenges around the world.

Source: BioSpectrum (Link to Full Article)

About the author

Amitabh Arora

Amitabh Arora has more than 18 years of experience promoting foreign direct investments (FDI), trade and economic relations between India and Switzerland, South Korea, United Kingdom and Canada. He is currently working as Director Key Accounts at the Greater Geneva Berne area (GGBa), the economic development agency of western Switzerland. GGBa offers a comprehensive range of services at no charge to foreign companies seeking to establish a presence in Switzerland. He is also the founder of FDITracker.com, tracking FDI developments worldwide. Amitabh has a Masters in International Business from the Indian Institute of Foreign Trade (IIFT) and a Bachelor of Business Studies (BBS) from College of Business Studies, India.